Use of urodilatin for treating chronic kidney failure with residual kidney functions

US6831064B1 · kind B1 · utility

Assignee

• Pharis Biotec GmbH · DE

Inventors

• Wolf-Georg Forssmann · Hannover, DE
• Kristin Forssmann · Heidgraben, DE
• Wolfgang Greb · Dinslaken, DE
• Markus Meyer · Hannover, DE

Key dates

• Filing date: Jul 18, 2002
• Grant date: Dec 14, 2004
• Expiry date: Aug 16, 2022

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P13/12
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Use of urodilatin for treating chronic renal insufficiency by stimulating the residual renal function.